Cases & Deals

City of Hope licenses its unique gene editing technology to Homology Medicines Inc.

Clients City of Hope

Jones Day advised City of Hope in connection with an exclusive, worldwide license of its pioneering AAV-based gene editing technology to Homology Medicines Inc., a newly-formed genetic medicines company. A City of Hope lab developed the single platform technology that enables both gene editing and gene therapy with a built-in in vivo delivery system. The foundation technology is a novel non-nuclease based gene editing platform that is initially being developed to help find cures for rare genetic diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.